[1] |
CAI Tao, SUN Lan-zhen, LAN Xiao-hong.
Analysis of factors affecting long-term prognosis of patients with drug-induced liver injury
[J]. Chinese Hepatolgy, 2021, 26(6): 674-676.
|
[2] |
CHEN Qiong, MEI Hong, GAO Yuan, XU Ping-ping, CHEN chen, WU Yu-ping.
Analysis of etiology and clinical features of infantile cholestatic hepatopathy
[J]. Chinese Hepatolgy, 2021, 26(6): 680-683.
|
[3] |
WANG Yan, WANG Yu, WANG Lan, TIAN Qiu-ju, YANG Rui-yuan, LI Ke-xin, LIU Li-wei, LU Yi-da, WANG Xiao-ming, WANG Yu, OU Xiao-juan, JIA Ji-dong, ZHAO Xin-yan.
The association between antinuclear antibody titers with the clinical features and prognosis of drug induced liver injury
[J]. Chinese Hepatolgy, 2021, 26(3): 237-242.
|
[4] |
WANG Tao, WANG Xue-wei, JIANG Yuan-ye, CAO Qin, JI Guang.
Analysis of 162 cases of drug-induced liver injury
[J]. Chinese Hepatolgy, 2021, 26(3): 243-246.
|
[5] |
LI Qing, ZHOU Tian-hui, MO Rui-dong, XIANG Xiao-gang, ZHAO Gang-de, ZHOU Hui-juan, XU Yu-min, CAI Wei, WANG Hui, XIE Qing, LAI Rong-tao.
The expression of type 3 innate lymphocytes in blood may have potential differential diagnosis value between drug-induced liver injury and autoimmune hepatitis
[J]. Chinese Hepatolgy, 2020, 25(8): 840-844.
|
[6] |
LI Liang, TAO Ying-min, ZHANG Xue-min, XIE Juan, CHEN Yuan.
Clinical significance of circulating hypoxia inducible factor-1α and cycloxygenase-2 in patients with drug-induced liver injury
[J]. Chinese Hepatolgy, 2020, 25(8): 848-852.
|
[7] |
YANG Rui-yuan, LIU Li-wei, LUO Juan, LI Ke-xin, TIAN Qiu-ju, WANG Yan, ZHAO Xin-yan, JIA Ji-dong.
A comparative study of predictive models for acute liver failure in drug-induced liver injury
[J]. Chinese Hepatolgy, 2020, 25(7): 671-675.
|
[8] |
LI Wen-ting, YANG Liang, HE Hong-liang, ZHAO Zong-hao, LI Yi.
Application of glucocorticosteroid in drug induced liver injury
[J]. Chinese Hepatolgy, 2020, 25(7): 676-678.
|
[9] |
WANG Li-ping, HE Ting-ting, ZHU Yun, WANG Zhong-xia, WANG Li-fu, SUN Yong-qiang, JING Jing, XU Wen-tao, YU Si-miao, SANG Xiu-xiu, TIAN Miao, REN Yue-bo, CUI Yan-fei, WANG Rui-lin.
Clinical study of two diagnostic criteria for chronic drug-induced liver injury
[J]. Chinese Hepatolgy, 2020, 25(6): 569-572.
|
[10] |
GAO Peng-bin, ZHENG Huan-wei, ZHAO Xiao-yan, WANG De-hua, QIN Hao, MENG Ming-hui, ZHANG Jian-ji, YAN Shuang-huan.
The clinical characteristics and prognosis of patients with HBV-ACLF treated by internal medicine
[J]. Chinese Hepatolgy, 2020, 25(4): 375-378.
|
[11] |
ZHOU Tian-hui, MO Rui-dong, HUANG Yan, LAI Rong-tao, CAI Wei, XIE Qing, TANG Wei-liang.
Serum fatty acid binding protein 4 in patients with drug-induced liver injury
[J]. Chinese Hepatolgy, 2020, 25(2): 158-161.
|
[12] |
YIN Jie, LIU Tao-tao, SHEN Xi-zhong.
Analysis of clinical characteristics in 116 patients with drug-induced liver injury
[J]. Chinese Hepatolgy, 2020, 25(11): 1205-1207.
|
[13] |
CHEN Shu-ping, AN Hong-jun, GAO Shui-ju, LI Wen-li.
Analysis of etiology, clinical characteristics and prognosis of 128 children with drug-induced liver injury
[J]. Chinese Hepatolgy, 2020, 25(11): 1208-1211.
|
[14] |
TIAN Chun-li, LIANG Ke-feng, ZHAO Yu.
Analysis of etiology and clinical characteristics of drug-induced liver injury in children
[J]. Chinese Hepatolgy, 2020, 25(1): 31-33.
|
[15] |
HAN Lin, YANG Zhao, LIANG Qing-sheng, HUANG Ang, SUN Ying, ZOU Zheng-sheng.
Clinical features of 100 patients with drug-induced liver failure
[J]. Chinese Hepatolgy, 2019, 24(3): 229-233.
|